Dr. Ben Fryer, Co-Founder and CEO of Pluristyx, presented to webinar participants the “how and why” of integrating high quality ancillary raw materials into cell therapy product development and the manufacturing workflow, beginning with the starting cell source and MCB.

Webinar Link: https://www.labroots.com/webinar/prepare-success-gmp-cell-banks-staged-standardized-platform-style-cell-production-process-2